Articles

‘I’m ready to walk away’: I have $400K in retirement savings and want to quit my job of 30 years. Can I do it?

“I really, really hate my job. I do work from home, but I’m very burned out.”

Versant is off to a rocky start on first day of trading after spinoff from Comcast

The early ratings for Versant are in — with shares of the new owner of cable television stalwarts like CNBC, USA Network and the recently rebranded MS NOW (formerly MSNBC) tumbling nearly 15% on their first day of trading.

Why chip stocks are extending their gains ahead of Nvidia’s CES speech

Lam, Applied Materials and KLA shares are some of the sector’s biggest winners upon heightened enthusiasm for the data-center build-out.

This is how JPMorgan Chase’s stock stands out in the elite $900 billion club

The company is poised to close with a market capitalization of more than $900 billion, putting it in an exclusive group — and one in which its stock is the cheapest.

The ‘Trump doctrine’ demands the U.S. get a better deal — and it’s paying dividends

How a full-page newspaper advertisement in 1987 became American foreign policy.

U.S. manufacturing slump shows little sign of ending, ISM shows

A closely watched index that measures U.S. manufacturing activity fell to 47.9% in December, the Institute for Supply Management said Monday. This is the lowest reading of the year and the 10th straight month of contraction in the factory sector.

New weight-loss pill version of Novo Nordisk’s Wegovy is now available. Here’s how rival stocks Lilly and Viking are reacting.

Novo Nordisk’s wildly successful obesity medicine is now available as a pill, making it the first GLP-1 pill for weight loss in the U.S.

5 smart moves to raise your credit score ASAP — and get better loan rates in 2026

MarketWatch talked to credit experts to develop an order of operations to improve your credit score fast, whether you have weeks or months.

These top-pick software stocks could deliver big gains in 2026, analysts say

Investors still need to be selective when playing the choppy software sector, but analysts see compelling opportunity in some high-profile stocks and under-the-radar plays.

ASML’s stock hits another record high after analyst upgrade

ASML shares rallied on Monday to make the stock one of the strongest-performing members of the Nasdaq 100 after an analyst upgrade due to demand from memory-chip producers.

These stocks stand to gain as the U.S. tightens its grip on Venezuelan oil

If the U.S. can exert control over Venezuela’s leadership and energy sector, the long-term implications could be substantial.

A small company can now advance its psychedelic into Phase 3. Here’s why that matters to other psychedelic biotechs.

GH Research’s stock rallied after saying the FDA lifted a hold on its experimental depression treatment.
1 65 66 67 68 69 2,579